In order to investigate whether the expression of NGK2D-Ls was also increased in primary HSPCs from patients with FA, we analyzed fresh BM CD34+ cells from 23 nonmosaic FA patients and 7 HDs (Figure 3 and Tables 1 and 2). The gene discussed is CD34; the disease is Friedreich ataxia.